4 October 2018 - Deborah Wilkes
Archived
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would have to be modified if the UK does not secure a deal with the European Union after its departure from the European Union and there is no implementation period.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.